AQR Capital Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.1M Buy
1,603,576
+976,570
+156% +$7.53M 0.01% 1292
2025
Q4
$5.53M Sell
627,006
-41,460
-6% -$228K ﹤0.01% 1521
2025
Q3
$3.34M Buy
668,466
+532,742
+393% +$2.47M ﹤0.01% 1682
2025
Q2
$641K Buy
135,724
+84,164
+163% +$368K ﹤0.01% 2469
2025
Q1
$237K Buy
51,560
+1,581
+3% +$7.37K ﹤0.01% 2800
2024
Q4
$239K Sell
49,979
-15,944
-24% -$76.6K ﹤0.01% 2601
2024
Q3
$309K Sell
65,923
-9,966
-13% -$53.4K ﹤0.01% 2382
2024
Q2
$429K Buy
75,889
+48,945
+182% +$253K ﹤0.01% 2119
2024
Q1
$111K Buy
26,944
+10,699
+66% +$42.8K ﹤0.01% 2329
2023
Q4
$68.6K Buy
+16,245
New +$65.5K ﹤0.01% 2295
2019
Q3
Sell
-17,911
Closed -$252K 2170
2019
Q2
$252K Hold
17,911
﹤0.01% 1925
2019
Q1
$330K Buy
17,911
+3,916
+28% +$89.2K ﹤0.01% 1938
2018
Q4
$366K Buy
+13,995
New +$329K ﹤0.01% 1893
2018
Q1
Sell
-11,896
Closed -$181K 2281
2017
Q4
$181K Hold
11,896
﹤0.01% 2166
2017
Q3
$213K Sell
11,896
-13,477
-53% -$226K ﹤0.01% 2157
2017
Q2
$414K Hold
25,373
﹤0.01% 1957
2017
Q1
$355K Buy
25,373
+11,400
+82% +$162K ﹤0.01% 1977
2016
Q4
$223K Buy
+13,973
New +$225K ﹤0.01% 2131
2015
Q1
Sell
-12,413
Closed -$178K 2321
2014
Q4
$178K Sell
12,413
-31,900
-72% -$377K ﹤0.01% 2385
2014
Q3
$460K Hold
44,313
﹤0.01% 1973
2014
Q2
$717K Sell
44,313
-30,200
-41% -$402K ﹤0.01% 1813
2014
Q1
$1.21M Hold
74,513
﹤0.01% 1602
2013
Q4
$925K Buy
74,513
+39,413
+112% +$396K ﹤0.01% 1773
2013
Q3
$385K Buy
35,100
+20,200
+136% +$216K ﹤0.01% 2107
2013
Q2
$120K Buy
+14,900
New +$100K ﹤0.01% 2272

Other funds holding VNDA